Pulmonary resection of metastatic renal cell carcinoma

Robert J. Cerfolio, Mark S. Allen, Claude Deschamps, Richard C. Daly, Steven L. Wallrichs, Victor F. Trastek, Peter C. Pairolero

Research output: Contribution to journalArticle

144 Citations (Scopus)

Abstract

Between 1965 and 1989, 96 consecutive patients (64 men and 32 women) underwent complete pulmonary resection for metastatic renal cell carcinoma. Median age was 69 years (range, 33 to 82 years). Median time between nephrectomy and pulmonary resection was 3.4 years (range, 0 to 18.4 years). Forty-eight patients had solitary metastasis, 16 had two, 18 had three, and 14 had more than three. Wedge excision was performed in 62 patients, segmentectomy in 3, lobectomy in 25, bilobectomy in 3, and pneumonectomy in 3. Fourteen patients had repeat thoracotomy for recurrent metastasis; 34 other patients also had complete resection of limited extrapulmonary disease. There were no operative deaths. Median follow-up was 3 years (range, 70 days to 19.0 years). Overall 5-year survival was 35.9%. Patients with solitary metastasis had a 5-year survival of 45.6% compared with 27.0% for patients with multiple metastases (p < 0.05). Patients with a tumor-free interval greater than the median of 3.4 years had a better survival (p = 0.05) than those with a tumor-free interval less than or equal to 3.4 years. Fiveyear survival for patients who underwent repeat thoracotomy or had complete resection of extrapulmonary disease did not differ from overall survival. We conclude that resection of renal lung metastasis is safe and effective, that patients with solitary metastasis have a better survival than those with multiple metastases, that resectable extrapulmonary disease does not necessarily contraindicate pulmonary resection, and that repeat thoracotomy is warranted in selected patients with recurrent lung metastases.

Original languageEnglish (US)
Pages (from-to)339-344
Number of pages6
JournalThe Annals of Thoracic Surgery
Volume57
Issue number2
DOIs
StatePublished - 1994

Fingerprint

Renal Cell Carcinoma
Lung
Neoplasm Metastasis
Survival
Thoracotomy
Segmental Mastectomy
Pneumonectomy
Nephrectomy
Neoplasms
Kidney

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Cerfolio, R. J., Allen, M. S., Deschamps, C., Daly, R. C., Wallrichs, S. L., Trastek, V. F., & Pairolero, P. C. (1994). Pulmonary resection of metastatic renal cell carcinoma. The Annals of Thoracic Surgery, 57(2), 339-344. https://doi.org/10.1016/0003-4975(94)90994-6

Pulmonary resection of metastatic renal cell carcinoma. / Cerfolio, Robert J.; Allen, Mark S.; Deschamps, Claude; Daly, Richard C.; Wallrichs, Steven L.; Trastek, Victor F.; Pairolero, Peter C.

In: The Annals of Thoracic Surgery, Vol. 57, No. 2, 1994, p. 339-344.

Research output: Contribution to journalArticle

Cerfolio, RJ, Allen, MS, Deschamps, C, Daly, RC, Wallrichs, SL, Trastek, VF & Pairolero, PC 1994, 'Pulmonary resection of metastatic renal cell carcinoma', The Annals of Thoracic Surgery, vol. 57, no. 2, pp. 339-344. https://doi.org/10.1016/0003-4975(94)90994-6
Cerfolio RJ, Allen MS, Deschamps C, Daly RC, Wallrichs SL, Trastek VF et al. Pulmonary resection of metastatic renal cell carcinoma. The Annals of Thoracic Surgery. 1994;57(2):339-344. https://doi.org/10.1016/0003-4975(94)90994-6
Cerfolio, Robert J. ; Allen, Mark S. ; Deschamps, Claude ; Daly, Richard C. ; Wallrichs, Steven L. ; Trastek, Victor F. ; Pairolero, Peter C. / Pulmonary resection of metastatic renal cell carcinoma. In: The Annals of Thoracic Surgery. 1994 ; Vol. 57, No. 2. pp. 339-344.
@article{370ae0d523e44e5c98e1d04c6f053c9e,
title = "Pulmonary resection of metastatic renal cell carcinoma",
abstract = "Between 1965 and 1989, 96 consecutive patients (64 men and 32 women) underwent complete pulmonary resection for metastatic renal cell carcinoma. Median age was 69 years (range, 33 to 82 years). Median time between nephrectomy and pulmonary resection was 3.4 years (range, 0 to 18.4 years). Forty-eight patients had solitary metastasis, 16 had two, 18 had three, and 14 had more than three. Wedge excision was performed in 62 patients, segmentectomy in 3, lobectomy in 25, bilobectomy in 3, and pneumonectomy in 3. Fourteen patients had repeat thoracotomy for recurrent metastasis; 34 other patients also had complete resection of limited extrapulmonary disease. There were no operative deaths. Median follow-up was 3 years (range, 70 days to 19.0 years). Overall 5-year survival was 35.9{\%}. Patients with solitary metastasis had a 5-year survival of 45.6{\%} compared with 27.0{\%} for patients with multiple metastases (p < 0.05). Patients with a tumor-free interval greater than the median of 3.4 years had a better survival (p = 0.05) than those with a tumor-free interval less than or equal to 3.4 years. Fiveyear survival for patients who underwent repeat thoracotomy or had complete resection of extrapulmonary disease did not differ from overall survival. We conclude that resection of renal lung metastasis is safe and effective, that patients with solitary metastasis have a better survival than those with multiple metastases, that resectable extrapulmonary disease does not necessarily contraindicate pulmonary resection, and that repeat thoracotomy is warranted in selected patients with recurrent lung metastases.",
author = "Cerfolio, {Robert J.} and Allen, {Mark S.} and Claude Deschamps and Daly, {Richard C.} and Wallrichs, {Steven L.} and Trastek, {Victor F.} and Pairolero, {Peter C.}",
year = "1994",
doi = "10.1016/0003-4975(94)90994-6",
language = "English (US)",
volume = "57",
pages = "339--344",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Pulmonary resection of metastatic renal cell carcinoma

AU - Cerfolio, Robert J.

AU - Allen, Mark S.

AU - Deschamps, Claude

AU - Daly, Richard C.

AU - Wallrichs, Steven L.

AU - Trastek, Victor F.

AU - Pairolero, Peter C.

PY - 1994

Y1 - 1994

N2 - Between 1965 and 1989, 96 consecutive patients (64 men and 32 women) underwent complete pulmonary resection for metastatic renal cell carcinoma. Median age was 69 years (range, 33 to 82 years). Median time between nephrectomy and pulmonary resection was 3.4 years (range, 0 to 18.4 years). Forty-eight patients had solitary metastasis, 16 had two, 18 had three, and 14 had more than three. Wedge excision was performed in 62 patients, segmentectomy in 3, lobectomy in 25, bilobectomy in 3, and pneumonectomy in 3. Fourteen patients had repeat thoracotomy for recurrent metastasis; 34 other patients also had complete resection of limited extrapulmonary disease. There were no operative deaths. Median follow-up was 3 years (range, 70 days to 19.0 years). Overall 5-year survival was 35.9%. Patients with solitary metastasis had a 5-year survival of 45.6% compared with 27.0% for patients with multiple metastases (p < 0.05). Patients with a tumor-free interval greater than the median of 3.4 years had a better survival (p = 0.05) than those with a tumor-free interval less than or equal to 3.4 years. Fiveyear survival for patients who underwent repeat thoracotomy or had complete resection of extrapulmonary disease did not differ from overall survival. We conclude that resection of renal lung metastasis is safe and effective, that patients with solitary metastasis have a better survival than those with multiple metastases, that resectable extrapulmonary disease does not necessarily contraindicate pulmonary resection, and that repeat thoracotomy is warranted in selected patients with recurrent lung metastases.

AB - Between 1965 and 1989, 96 consecutive patients (64 men and 32 women) underwent complete pulmonary resection for metastatic renal cell carcinoma. Median age was 69 years (range, 33 to 82 years). Median time between nephrectomy and pulmonary resection was 3.4 years (range, 0 to 18.4 years). Forty-eight patients had solitary metastasis, 16 had two, 18 had three, and 14 had more than three. Wedge excision was performed in 62 patients, segmentectomy in 3, lobectomy in 25, bilobectomy in 3, and pneumonectomy in 3. Fourteen patients had repeat thoracotomy for recurrent metastasis; 34 other patients also had complete resection of limited extrapulmonary disease. There were no operative deaths. Median follow-up was 3 years (range, 70 days to 19.0 years). Overall 5-year survival was 35.9%. Patients with solitary metastasis had a 5-year survival of 45.6% compared with 27.0% for patients with multiple metastases (p < 0.05). Patients with a tumor-free interval greater than the median of 3.4 years had a better survival (p = 0.05) than those with a tumor-free interval less than or equal to 3.4 years. Fiveyear survival for patients who underwent repeat thoracotomy or had complete resection of extrapulmonary disease did not differ from overall survival. We conclude that resection of renal lung metastasis is safe and effective, that patients with solitary metastasis have a better survival than those with multiple metastases, that resectable extrapulmonary disease does not necessarily contraindicate pulmonary resection, and that repeat thoracotomy is warranted in selected patients with recurrent lung metastases.

UR - http://www.scopus.com/inward/record.url?scp=0028195038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028195038&partnerID=8YFLogxK

U2 - 10.1016/0003-4975(94)90994-6

DO - 10.1016/0003-4975(94)90994-6

M3 - Article

C2 - 8311594

AN - SCOPUS:0028195038

VL - 57

SP - 339

EP - 344

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 2

ER -